首页> 外文期刊>Gynecological endocrinology: the official journal of the International Society of Gynecological Endocrinology >Does myo-inositol oxygenase, the only enzyme to catalyze myo-inositol in vivo, play a role in the etiology of polycystic ovarian syndrome?
【24h】

Does myo-inositol oxygenase, the only enzyme to catalyze myo-inositol in vivo, play a role in the etiology of polycystic ovarian syndrome?

机译:肌醇氧氧酶,唯一催化体内肌醇的酶,在多囊卵巢综合征的病因中发挥作用吗?

获取原文
获取原文并翻译 | 示例
           

摘要

In polycystic ovary syndrome (PCOS), myo-inositol (MI) supplements have shown many beneficial effects. In this study, therefore, we aimed to investigate the serum level of myo-inositol oxygenase (MIOX), which is the only enzyme catalyzing MI in vivo, in patients with PCOS. Serum MIOX enzyme levels and other laboratory parameters were compared between sixty patients, who were
机译:在多囊卵巢综合征(PCOS)中,肌醇肌醇(MI)补充剂表现出许多有益的效果。 因此,在这项研究中,我们旨在研究肌醇氧化酶(MiOx)的血清水平,这是PCOS患者体内唯一的酶催化MI。 在六十名患者之间比较了血清miox酶水平和其他实验室参数

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号